Canterbury DHB
In the seven schedules, drug dosage is related either to the patient’s actual body weight or by calculating the Body Surface area (BSA). Any dose reduction due to renal dysfunction or obesity is done by the Haematology Pharmacist in conjunction with the Transplant Consultant. See also Cytotoxic Drugs in the Drug Usage section.
Day |
Summary |
-1 |
Melphalan 200 mg/m2 |
0 |
Bone marrow/PBSC return. Ensure the stem cell infusion is given at least 24 hours post melphalan. |
For more details, refer to:
|
Topic Code: 10208